Off-label prescribing in a French hospital

被引:17
作者
Cras, Audrey
Marie-Agnes Conscience
Rajzbaum, Gerald
Louet, Agnes Lillo-Le
Lopez, Nathalie
Tersen, Isabelle
Bezie, Yvonnick
机构
[1] St Joseph Hosp Fdn, Dept Pharm, F-75014 Paris, France
[2] St Joseph Hosp Fdn, Dept Rheumatol, F-75014 Paris, France
[3] Georges Pompidou European Hosp, Dept Pharmacol, F-75015 Paris, France
来源
PHARMACY WORLD & SCIENCE | 2007年 / 29卷 / 02期
关键词
adverse drug reactions; France; hospital; off-label prescribing; prescribing;
D O I
10.1007/s11096-006-9064-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective In contrast to paediatrics patients, data concerning the extent of off-label prescribing for adult patients are limited. The aim of our study was to investigate the frequency of off-label drug use for adult patients in a French general hospital. Method The study was conducted on a Wednesday in November 2004. Prescribing was prospectively assessed on the basis of conformity with the marketing authorizations. Results A total of 1341 prescriptions for 192 hospitalized patients were analysed. Twenty three per cent of the prescriptions were off-label. Among all patients, 70% received at least one off-label medicine. Most off-label prescriptions were related to an unapproved indication (75%). The main other reasons were dosage (14%) and dosing schedule (9%). Anti-thrombotic and anti-ulcer agents were found on more than 40% of the off-label prescriptions. Conclusion Off-label prescriptions occur frequently in the hospital and often alternatives with the proper marketing authorizations are available. An increased involvement of hospital pharmacists should reduce the incidence of off-label prescribing and thus contribute to patient safety and possibly cost reduction.
引用
收藏
页码:97 / 100
页数:4
相关论文
共 11 条
[1]  
Albaladejo P, 2001, PRESSE MED, V30, P1484
[2]   Effect of computerized physician order entry and a team intervention on prevention of serious medication errors [J].
Bates, DW ;
Leape, LL ;
Cullen, DJ ;
Laird, N ;
Petersen, LA ;
Teich, JM ;
Burdick, E ;
Hickey, M ;
Kleefield, S ;
Shea, B ;
Vander Vliet, M ;
Seger, DL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (15) :1311-1316
[3]  
Choonara Imti, 2004, Expert Opin Drug Saf, V3, P81, DOI 10.1517/14740338.3.2.81
[4]   Unlicensed and off-label uses of drugs in paediatrics: a review of the literature [J].
Cuzzolin, L ;
Zaccaron, A ;
Fanos, V .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2003, 17 (01) :125-131
[5]   An update on aspirin in the primary prevention of cardiovascular disease [J].
Eidelman, RS ;
Hebert, PR ;
Weisman, SM ;
Hennekens, CH .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (17) :2006-2010
[6]   Cost-minimization analysis of treatment of gastroesophageal reflux disease -: Implications of varying holding time on conclusions [J].
Kivioja, A ;
Linnosmaa, I ;
Vehviläinen, A ;
Vohlonen, K .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 21 (2-3) :171-178
[7]   Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units [J].
Kucukarslan, SN ;
Peters, M ;
Mlynarek, M ;
Nafziger, DA .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (17) :2014-2018
[8]   Off-label prescribing in oncology [J].
Poole, SG ;
Dooley, MJ .
SUPPORTIVE CARE IN CANCER, 2004, 12 (05) :302-305
[9]   Off label use: a mistake or a need? [J].
REVISTA DE SAUDE PUBLICA, 2012, 46 (02) :398-399
[10]   A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients [J].
Samama, MM ;
Cohen, AT ;
Darmon, JY ;
Desjardins, L ;
Eldor, A ;
Janbon, C ;
Leizorovicz, A ;
Nguyen, H ;
Olsson, CG ;
Turpie, AG ;
Weisslinger, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (11) :793-800